Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
LA TERAPUTICA
Interno: Goicochea Lugo,
Sergio
EPIDEMIOLOGA
ETIOLOGA
Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on
the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):S27
FISIOPATOLOGA
Tom van der Poll, Steven M Opal.Pathogenesis, treatment, and prevention of pneumococcal
pneumonia.Lancet 2009; 374: 154356.
FISIOPATOLOGA
DIAGNSTICO
Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on
the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):S27
ABORDAJE
TERAPUTICA
Adjuvantes
Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on
the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):S27
TERAPUTICA
GLUCOCORTICOIDES
Blum CA, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a
multicentre, double-blind, randomised, placebo-controlled trial.Lancet. 2015;385(9977):1511.
TERAPUTICA
INHIBIDOR DE LA VIA DEL FACTOR
TISULAR
TIFACOGIN: inhibidor de la va del factor
tisular recombinante e inhibidor sistmico de
la coagulacin. No recomendado en NAC
severa, no mejora mortalidad.
TERAPUTICA
NUEVAS ALTERNATIVAS
CEFALOSPORINAS
KETLIDOS
QUINOLONAS
OTROS
Viasus D, Garcia-Vidal C, Carratal J.Advances in antibiotic therapy for community-acquired pneumonia.Curr
Opin Pulm Med. 2013;19(3):209-15.
NUEVAS ALTERNATIVAS
CEFALOSPORINAS
CEFTAROLIN (5TA) 600 mg c/ 12h EV: aprobado por FDA,
frente a MRSA (IN-VITRO), beneficioso en NAC no-UCI (=
ceftriaxona) con PSI III-IV (Estudios FOCUS 1 y 2). Escasos
datos para PSI I,II,V, enf. Renal, inmunosupresin, atipicos,
pctes en UCI.
NUEVAS ALTERNATIVAS
KETLIDOS
NUEVAS ALTERNATIVAS
QUINOLONAS
Inhibicin de DNA
Girasa
NUEVAS ALTERNATIVAS
OTROS
NUEVAS ALTERNATIVAS
NUEVAS ALTERNATIVAS
GRACIAS